China’s opaque and deliberately slow biotech approval process is costing U.S. farmers, exporters, seed companies and others billions of dollars in lost sales, according to a new analysis being released today by Informa’s Agribusiness Consulting.
Shining Light on Farm & Food Policy for 20 Years.
Thursday, September 26, 2024